Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Project Grant

McMaster University

$1,032,750.00

Overcoming Salmonella immune evasion with targeted therapeutic strategies

FY 2025-26

Summary
Drug-resistant infections are a growing global health crisis that threatens the progress of modern medicine. One such threat is invasive Salmonella, a life-threatening bacterial infection that causes bloodstream infections, especially in children and immunocompromised individuals. Treatment is becoming increasingly difficult as the bacteria develop resistance to the most powerful antibiotics. This project, led by Canadian scientists, will uncover how Salmonella evades the immune system and survives inside immune cells. We aim to identify how the immune system fights Salmonella, how the bacteria fight back, and how these interactions cause disease. Understanding this arms race will allow us to find weak points that can be targeted by new therapies that we explore in this research proposal. We will pursue three goals. First, we will map out how Salmonella adapts inside immune cells and identify which immune responses are most effective. Second, we will develop drug combinations that restore the power of "last-resort" antibiotics by using small molecules that work together with the drug to kill resistant bacteria. Third, we will identify existing drugs that can be repurposed to boost the immune system's ability to clear Salmonella infections. This research will support Canada's role in global health innovation by addressing an emerging disease that disproportionately affects vulnerable populations, even in Canada. Our discoveries will contribute to international efforts to combat antimicrobial resistance and improve health equity worldwide.
Program
Project Grant
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
564712
Name
Coombes Brian K
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Infection and Immunity
Theme2
Biomedical
Prcname2
Microbiology & Infectious Diseases
Projecttitle
Overcoming Salmonella immune evasion with targeted therapeutic strategies
Programtype2
Operating Grants
Orgnameinp2
McMaster University
Cihramount2
$1,032,750
Cihrequipment2
$0
Programname2
Project Grant
Keyworddelim
Antimicrobial Resistance; Drug Discovery; High-Throughput Screening; Host-Pathogen Interactions; Infection Biology; Salmonella
Abstract
Drug-resistant infections are a growing global health crisis that threatens the progress of modern medicine. One such threat is invasive Salmonella, a life-threatening bacterial infection that causes bloodstream infections, especially in children and immunocompromised individuals. Treatment is becoming increasingly difficult as the bacteria develop resistance to the most powerful antibiotics. This project, led by Canadian scientists, will uncover how Salmonella evades the immune system and survives inside immune cells. We aim to identify how the immune system fights Salmonella, how the bacteria fight back, and how these interactions cause disease. Understanding this arms race will allow us to find weak points that can be targeted by new therapies that we explore in this research proposal. We will pursue three goals. First, we will map out how Salmonella adapts inside immune cells and identify which immune responses are most effective. Second, we will develop drug combinations that restore the power of "last-resort" antibiotics by using small molecules that work together with the drug to kill resistant bacteria. Third, we will identify existing drugs that can be repurposed to boost the immune system's ability to clear Salmonella infections. This research will support Canada's role in global health innovation by addressing an emerging disease that disproportionately affects vulnerable populations, even in Canada. Our discoveries will contribute to international efforts to combat antimicrobial resistance and improve health equity worldwide.
Competitiondate
202603
Approvedterm2
5 yrs 0 mth
Pinamesdelim
Coombes, Brian K
Approvedterm
5 ans 0 mois
Cihrcontribution2
~ $1,032,750~ $0~